These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10294587)

  • 1. Examining drug usage in long-term care facilities. CLTC's 1989 Nursing Home Drug Utilization Survey.
    Thomas M
    Contemp Longterm Care; 1989 Aug; 12(10):22, 26. PubMed ID: 10294587
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug utilization in nursing homes: the D.O.N.'s perspective.
    Contemp Longterm Care; 1989 Aug; 12(10):28-9. PubMed ID: 10294588
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug safety for the long-term. Long-term care facilities have the same medication management concerns as hospitals, plus others.
    Joch A
    Healthc Inform; 2003 Jul; 20(7):38. PubMed ID: 12899061
    [No Abstract]   [Full Text] [Related]  

  • 4. Utilization of PRN drugs in long-term care facilities in South Carolina.
    Aycock EK; Osemene PI; Sear AM
    J S C Med Assoc; 1979 Dec; 75(12):631-4. PubMed ID: 294483
    [No Abstract]   [Full Text] [Related]  

  • 5. CLTC's 1987 Survey of Multi-Facility Operators. Rating the top for-profit and not-for-profit performers in long-term care.
    Contemp Longterm Care; 1987 Dec; 10(12):27-37. PubMed ID: 10285191
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug utilization review in long-term care.
    Sherman DS
    Contemp Longterm Care; 1989 Aug; 12(10):79-81. PubMed ID: 10294592
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication: greater use, closer scrutiny.
    Rajecki R
    Contemp Longterm Care; 1990 Aug; 13(8):32, 34, 76. PubMed ID: 10105630
    [No Abstract]   [Full Text] [Related]  

  • 8. For the patient. Many nursing home patients do not receive diabetes medicine.
    Allsworth JE; Toppa R; Palin NC; Lapane KL
    Ethn Dis; 2005; 15(2):351. PubMed ID: 15825983
    [No Abstract]   [Full Text] [Related]  

  • 9. Unit-dose systems: drug waste and drug processing time in a long-term care facility.
    Evens RP; Yanchick V
    Hosp Formul; 1984 Jun; 19(6):454-8. PubMed ID: 10266564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey.
    Doshi JA; Shaffer T; Briesacher BA
    J Am Geriatr Soc; 2005 Mar; 53(3):438-43. PubMed ID: 15743286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testimony to the House Select Committee on Aging -- drugs in nursing homes.
    J Am Health Care Assoc; 1981 Jan; 7(1):10-1. PubMed ID: 10249767
    [No Abstract]   [Full Text] [Related]  

  • 12. The cost benefit of drug reviews in long term care facilities.
    Kidder SW
    J Am Health Care Assoc; 1982 May; 8(3):11-3, 16. PubMed ID: 10309610
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost benefit of drug reviews in long-term care facilities.
    Kidder SW
    Todays Nurs Home; 1982 May; 3(5):14-5, 32, 34. PubMed ID: 10309614
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug waste in long-term care facilities: a costly problem.
    Boisseree VR
    J Long Term Care Adm; 1985; 13(2):55-60. PubMed ID: 10272430
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic usage in long-term care facility geriatric patients.
    Cooper JW; Francisco GE
    Hosp Formul; 1981 Apr; 16(4):407-9, 412-3, 417-9. PubMed ID: 10250719
    [No Abstract]   [Full Text] [Related]  

  • 16. The value of pharmacist-conducted drug regimen review in nursing facilities.
    Nagle BA; Erwin WG
    Curr Concepts Hosp Pharm Manage; 1989; 11(4):16-9. PubMed ID: 10313303
    [No Abstract]   [Full Text] [Related]  

  • 17. Medication management.
    Lamy PP; Michocki RJ
    Clin Geriatr Med; 1988 Aug; 4(3):623-38. PubMed ID: 3136904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing the accumulation of surplus controlled substances at long term care facilities. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2005 May; 70(92):25462-6. PubMed ID: 15892213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redesign in the long-term care industry: a restraint reduction or restraint elimination program in the nursing home.
    Wiley B
    J Health Hum Serv Adm; 2000; 23(2):214-41. PubMed ID: 11481998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of psychotropic drugs in nursing homes.
    Gurvich T; Cunningham JA
    Am Fam Physician; 2000 Mar; 61(5):1437-46. PubMed ID: 10735348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.